1. Efficacy and safety of recombinant human activated protein C for severe sepsis;Bernard;The New England Journal of Medicine,2001
2. Comparative analysis of the human macrophage inflammatory protein family of cytokines (chemokines) on proliferation of human myeloid progenitor cells. Interacting effects involving suppression, synergistic suppression, and blocking of suppression;Broxmeyer;Journal of Immunology,1993
3. Platelet factor 4 binds to interleukin 8 receptors and activates neutrophils when its N terminus is modified with Glu-Leu-Arg;Clark-Lewis;Proceedings of the National Academy of Sciences of the United States of America,1993
4. −245bp of 5′-flanking region from the human platelet factor 4 gene is sufficient to drive megakaryocyte-specific expression in vivo;Cui;Blood,1998
5. Randomized trial of recombinant platelet factor 4 versus protamine for the reversal of heparin anticoagulation in humans;Dehmer;Circulation,1996